Meta Partners with Childhelp to Develop Sextortion Prevention Module for Childhelp Speak Up Be Safe Curriculum

PHOENIX, Feb. 11, 2025 (GLOBE NEWSWIRE) — Childhelp, a national nonprofit dedicated to the prevention and treatment of child abuse, is excited to announce a partnership with Meta to fund the development and launch of “Staying Safe from Online Harm,” a sextortion prevention curriculum module within the Childhelp Speak Up Be Safe program. This module […]

Ero Copper Announces 2024 Production Results, 2025 Guidance and Updated Three-Year Production Outlook

(TSX:ERO),(NYSE:ERO), (all amounts in US dollars, unless otherwise noted) VANCOUVER, British Columbia, Feb. 11, 2025 (GLOBE NEWSWIRE) — Ero Copper Corp. (TSX: ERO, NYSE: ERO) (“Ero” or the “Company”) is pleased to announce its 2024 production results and 2025 guidance as well as an updated three-year production outlook. HIGHLIGHTS 2024 Production Results Record quarterly copper

Diversified Energy’s Unique Strategy Produces Reliable Cash Flow and Strong Full Year 2024 Results

(LSE:DEC),(NYSE:DEC), Seventh Year in a Row of Approximately 50% or Better Cash Margins Cash Flow Growth Initiatives Contributed Over $50 million in Cash Flow Company Returned Over $105 million to Shareholders in 2024 BIRMINGHAM, Ala., Feb. 11, 2025 (GLOBE NEWSWIRE) — Diversified Energy Company PLC (LSE: DEC, NYSE: DEC) (“Diversified” or the “Company”) is pleased

LEEF Brands Expands Production Capacity to Meet Strong Demand, Secures 2025 Cultivation Licenses

(CNSX:LEEF.CN),(OTC US:LEEEF),(Other OTC:LEEEF),(CNSX:LEEF), VANCOUVER, British Columbia, Feb. 11, 2025 (GLOBE NEWSWIRE) — LEEF Brands Inc. (CSE: LEEF) (OTCQB: LEEEF) (the “Company” or “LEEF Brands”), one of California's largest and most sophisticated cannabis companies, announced today substantial increases in production capacity across its concentrate lines to address increasing market demand. The Company has completed significant expansions

Aya Gold & Silver Announces January 2025, Fourth Quarter and Full Year 2024 Production Results

(TSX:AYA),(OTC US:AYASF),(Other OTC:AYASF), MONTREAL, Feb. 11, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce production of 491,310 ounces (“oz”) of silver (“Ag”) in Q4-2024 at its Zgounder Silver Mine, located in the Kingdom of Morocco. In addition, Aya is pleased to report

Marimaca Appoints Stantec to Progress PEA for the Integration of the Pampa Medina Project

(TSX:MARI),(OTC US:MARIF),(Other OTC:MARIF), VANCOUVER, British Columbia, Feb. 11, 2025 (GLOBE NEWSWIRE) — Marimaca Copper Corp. (“Marimaca” or the “Company”) (TSX: MARI) is pleased to announce that it has commenced an Integration Preliminary Economic Assessment (“PEA“) for its Pampa Medina Project Area (“Pampa Medina“), located approximately 25km from the planned development at the Marimaca Oxide Deposit

Tilray Expands Medical Cannabis Portfolio in Germany

(NASDAQ:TLRY),(TSX:TLRY), NEUMÜNSTER, Germany, Feb. 11, 2025 (GLOBE NEWSWIRE) — Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, is pleased to announce the expansion of its industry-leading medical

Lantronix Appoints Steve Burrington as Vice President of Global Research and Development

(NASDAQ:LTRX), IRVINE, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX) (“the Company”), a global leader of compute and connectivity for IoT solutions enabling AI Edge Intelligence, is proud to announce the appointment of Steve Burrington as Vice President of Global Research and Development. Burrington will oversee all aspects of product development and

Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update

(NasdaqGM:THRD), THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU) Company initiating process to leverage balance sheet strength to maximize shareholder value Cash and cash equivalents of approximately $285 million as of December 31, 2024 (unaudited) Management to hold conference call/webcast today Tuesday, February 11, 2025, at 8:00

Arvinas Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

(NASDAQ:ARVN), – Announced that topline data from the monotherapy Phase 3 VERITAC-2 trial is anticipated in 1Q25 – – Presented Phase 1b data from the TACTIVE-U sub-study of vepdegestrant in combination with abemaciclib that demonstrated encouraging clinical activity (clinical benefit rate: 62.5%; overall response rate: 26.7%) in patients previously treated with a CDK4/6 inhibitor –

Scroll to Top